The Internal Revenue Service is on a roll! After announcing that the 2014 tax season would open on January 31, 2014, for individual taxpayers, the IRS has now announced that they will begin accepting 2013 business tax returns on Monday, January 13, 2014. This start date applies to both electronically-filed and paper-filed returns.
Business tax returns include any return that posts on the IRS Business Master File (BMF). Those BMF returns include a variety of income tax and information returns including:
Federal form 1120 (corporations) Federal form 1120S (S corporations) Federal form 1065 (partnerships or entities taxed as partnerships) Federal form 1041 (trusts and estates) Federal form 720 (excise) Federal form 940 (FUTA) Federal form 941 (FICA) Federal form 2290 (Heavy Highway Vehicle Use Tax)Corporate returns are generally due on March 15 but since March 15 falls on a Saturday in 2014, the due date for forms 1120 and forms 1120S will be March 17, 2014.
Top 5 Prefered Companies To Invest In Right Now: US Ecology Inc.(ECOL)
US Ecology, Inc., through its subsidiaries, provides waste treatment, disposal, recycling, and transportation services to commercial and government entities in the United States. The company offers treatment and disposal services for radioactive, hazardous, polychlorinated biphenyl, and non-hazardous industrial wastes. Its customers include oil refineries, chemical production facilities, manufacturers, electric utilities, steel mills, biotechnology companies, military installations, waste brokers/aggregators, and medical and academic institutions. The company was formerly known as American Ecology Corporation and changed its name to US Ecology, Inc. in February 2010. US Ecology, Inc. was founded in 1952 and is headquartered in Boise, Idaho.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, hazardous waste disposal specialist US Ecology (NASDAQ: ECOL ) has earned a coveted five-star ranking.
- [By Damian Illia] ides waste management and recycling services to manufacturing, industrial and energy-related sectors. The company�� five waste sites treat hazardous and non-hazardous industrial waste, as well as radioactive and PCB waste. In addition, the company麓s Robstown treatment plant in Texas counts with a thermal desorption unit that treats refinery sludge.
In the following sections I will show you that we are dealing with a very profitable growth stock, that has an above average ROE rate of 13.89%, and operates with a net margin of 15.99%.
Holding a Strong Position in the Market
ECOL has two revenue streams. Business contracts to treat customers��periodic disposal needs on the one hand, and event-driven services that apply to special projects or cleanup work on the other.
Furthermore, the company has a wide economic moat largely stemming from three factors: its efficient scale, its high switching costs and its intangible assets. Of the 20 commercial hazardous-waste landfills operational in the U.S., the majority are run by US Ecology and its main competitors Waste Management Inc. (WM), and Clean Harbors Inc. (CLH). With barriers to entry stemming from regulatory permits, and a limited market size, ECOL has managed to achieve an efficient scale in the market with five hazardous waste-sides. The company�� intangible assets consist of long-term regulatory permits, which enable US Ecology to posses a ��atekeeper privilege��regarding barriers to new entrants. In addition, customer switching costs are high, thus further adding to the firm�� ability to sustain growth in the long term.
Good Investments and New Management Should Ensure Profitable Growth
A range of new treatment services should also help ensure profitable growth for coming years. For example, the Texas facility which operates a new thermal desorption technology for oil refinery sludge since 2008 has been responsible for 10% of revenue and is expected to keep grow
- [By Lauren Pollock]
Among the stocks to watch in Monday’s session are US Ecology Inc.(ECOL), Akamai, and Dow Chemical Co.(DOW)
US Ecology again raised its earnings guidance for the year, pointing to strong volumes and accelerated project shipments, but warned its results for next year may take a hit as a result. The company, which provides waste- management and recycling services, also outlined plans to offer about $100 million in stock. Shares dropped 10% to $34.51 premarket.
- [By Damian Illia]
As we can see, the firm has a higher ROE than Amrep Corporation (AXR) but is well below the one registered by US Ecology Inc. (ECOL) and Cintas Corporation (CTAS).
Top 10 Industrial Disributor Stocks To Buy For 2014: Time Inc (TIME)
Time Inc., incorporated on September 28, 1988, is a magazine publisher in the United States. As of March 31, 2014, the Company publishes 23 magazines in print in the United States, including People, Sports Illustrated, InStyle, Time, Real Simple, Southern Living, Entertainment Weekly and Fortune and over 70 magazines outside the United States, primarily through IPC Magazines Group Limited (IPC) in the United Kingdom and Grupo Editorial Expansion (GEX) in Mexico. On April 30, 2014, the Company acquired the IPC publishing business in the United Kingdom, which was previously owned by a wholly-owned subsidiary of Time Warner (the IPC Purchase). In June 2014, Time Inc acquired Cozi Inc., a Seattle-based technology company with a portfolio of mobile and digital family organizing tools
The Company�� United States and United Kingdom print magazines is also available as tablet editions on digital devices and platforms. In addition, as of March 31, 2014, it operated over 45 Websites that collectively have tens of millions of average monthly visitors globally. It also operates an integrated publishing business that provides content marketing, targeted local print and digital advertising programs, branded book publishing and marketing and support services, including magazine subscription sales services, retail distribution and marketing services and customer service and fulfillment services, to the Company and other third-party clients, including other magazine publishers.
Advisors' Opinion:- [By Paul Vigna]
Time Inc.(TIME), the former Time Warner Inc.(TWX) publishing business, lowered its full-year revenue outlook, as the company looks to counteract weakness in print advertising. Shares were inactive premarket.
- [By Vera Yuan]
During the quarter we initiated a position in Publicis (1.0%), and exited the last of our position in Admiral. We added further to the recently initiated position in Time Warner (TWX)(3.6%), partly funded by selling a small position in Time Inc. (TIME), the magazine business spun off from the parent. We also added to and reduced select Consumer Staples, Information Technology, Industrial and Financials names.
Top 10 Industrial Disributor Stocks To Buy For 2014: Novo Nordisk A/S (NVO)
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes care segment covers insulins, oral antidiabetic drugs, and other protein-related products and projects comprising glucagon and protein-related delivery systems, as well as GLP-1 analogue. The Biopharmaceuticals segment provides products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation therapy. Its products are marketed and distributed through subsidiaries, distributors, and independent agents in 180 countries. Novo Nordisk A/S has a collaboration agreement with Archimedes, Inc. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Advisors' Opinion:- [By Ben Levisohn]
We continue to argue Sanofi offers near term momentum. This is based on scope for pipeline expectations to rise (today�� news on Dengue vaccine and recent PCSK9 data should help), coupled with an attractive valuation and earnings upside risk going into Q3. Sanofi trades at a�>10%�PE discount to�the sector yet offers comparable growth (5YR EPS CAGR 10%). That said, we retain our Neutral rating as we have�higher conviction on the�LT�fundamentals elsewhere in the sector, and�remain concerned about the sustainability of growth for the diabetes franchise (>30% of profits) post 2017. Preferred Pharma plays include AstraZeneca (AZN), Bayer, Novo Nordisk (NVO) and UCB. Bristol-Myers Squibb (BMY)�and Pfizer (PFE) are our preferred US plays.
- [By Maxx Chatsko]
The company will now compete more readily with industry leaders Novozymes from Novo Nordisk (NYSE: NVO ) and Genencor from DuPont (NYSE: DD ) . However, the biggest effects could be felt at Codexis (NASDAQ: CDXS ) , which has also licensed the cutting-edge host organism from Dyadic. Will BASF's push into industrial enzymes, specifically using the C1 platform, vindicate Codexis or shove it out of the way?
Top 10 Industrial Disributor Stocks To Buy For 2014: China North East Petroleum Holdings Limited(NEP)
China North East Petroleum Holdings Limited engages in the exploration and production of crude oil in northern China. As of December 31, 2010, it operated 295 producing wells with proven reserves of 5,476,200 barrels of crude oil at Qian?an 112, Hetingbao 301, Daan 34, and Gudian 31 oilfields. The company, through its subsidiary, Song Yuan Tiancheng Drilling Engineering Co., Ltd., provides contract land drilling and other oilfield services for state-owned and non-state-owned oil companies. China North East Petroleum Holdings Limited is headquartered in Song Yuan City, the People?s Republic of China.
Advisors' Opinion:- [By Ben Levisohn]
Krishna and Krauklis note that Buffalo Wild Wings, Nextera Energy (NEP), Rexnord Corp (RXN), and The Advisory Board (ABCO) should benefit from recent acquisitions that should boost revenue growth, while�Buffalo Wild Wings and Cavium (CAVM) should see improvements thanks to the adoption of new technology that will help boost margins. Terex, The Advisory Board, and�Rexnord should get a boost from cost cutting, Krishna and Krauklis say.
- [By Robert Rapier]
Another YieldCo,�Nextera Energy Partners�(NYSE: NEP) which will own and operate renewable energy plants built by�NextEra Energy�(NYSE: NEE) launched June 27. NEP priced its IPO at $25 per share, then saw the share price surge to $32.36 on the first day of trading. NEP�� initial portfolio will consist of wind and solar farms in the US and Canada with a total generating capacity just under a gigawatt.
- [By David Dittman]
Question: Dave, any thoughts on NextEra Energy Partners LP (NYSE: NEP)? And, if you can build on that, maybe talk about how to approach an initial public offering (IPO) in general. Thanks.
Top 10 Industrial Disributor Stocks To Buy For 2014: Cellular Dynamics International Inc (ICEL)
Cellular Dynamics International, Inc., incorporated on November 16, 2007, develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The Company�� iCell Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). Customers use its iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in researching cellular therapeutics. The Company�� iCell product line includes four different cell types: cardiomyocytes, neurons, hepatocytes and endothelial cells. The Company is actively developing an additional seven different cell types. iCell products are a consumable designed to be used once and then reordered.
The Company manufactures its iCell products from its iPSCs. An iPSC is a cell that has the ability both to replicate indefinitely and to be transformed into any cell type in the human body. The Company�� iCell O/S consists of six products, which include iCell Cardiomyocytes, iCell Neurons, iCell Endothelial Cells, iCell Hepatocytes and MyCell.
Advisors' Opinion:- [By John Udovich]
Stem cells may not be in the news much�as the sector has moved beyond the use of embryotic�ones, but small cap stem cell stocks Cellular Dynamics International Inc (NASDAQ: ICEL), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been fairly active over the past several trading days as ICEL went public, ISCO raised additional funding and BRTX grabbed more attention:
Top 10 Industrial Disributor Stocks To Buy For 2014: Dr. Reddy's Laboratories Ltd(RDY)
Dr. Reddy?s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec Internatio nal for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddy?s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.
Advisors' Opinion:- [By Rich Duprey]
Following FDA approval of its abbreviated new drug application, or ANDA,�Dr. Reddy's Laboratories (NYSE: RDY ) announced today that it launched its lamotrigine extended-release tablets, the generic version of GlaxoSmithKline's Lamictal.�
- [By Dan Carroll]
The company's generic drug segment should also help push emerging market sales. Abbott markets generic pharmaceuticals outside the U.S. only, and while the division isn't growth-oriented -- sales actually fell around 2% for the quarter -- it provides an entry for the company to push into lucrative new markets such as India, where generics make up the large majority of the country's retail market. The company will face tougher competition in this industry, however: Firms such as India-based Dr. Reddy's (NYSE: RDY ) have also pushed hard into emerging markets lately, and Dr. Reddy's in particular should benefit from its being headquartered in one of the industry's top locales.
- [By Benjamin Shepherd] We’re now into day 15 of the US government shutdown, as House Republicans stubbornly try to defund Obamacare. No matter what sort of deal is eventually struck, health care costs aren’t likely to come down any time soon. And that’s good news for generic drug makers.
Dr. Reddy’s Laboratories (NYSE: RDY) is one of the biggest players in generic drugs, offering more than 200 off-brand medications in the areas of cardiovascular disease, pain management and oncology, among others. In fact, this India-based company has become one of the largest makers of generics in the world, helping to drive more than 20 percent annual compounded earnings growth at the company over the past decade.
Top 10 Industrial Disributor Stocks To Buy For 2014: PIMCO Municipal Income Fund III(PMX)
PIMCO Municipal Income Fund III is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Co LLC. It invests in fixed income markets. The fund invests in a portfolio of municipal bonds, including long and short U.S. Treasury Notes, and U.S. Treasury Bond Futures. PIMCO Municipal Income Fund III was formed in 2002 and is domiciled in United States.
Advisors' Opinion:- [By maarnio]
Spectral is focused on the development and commercialization of a treatment for severe sepsis utilizing its Endotox in Activity Assay (EAA) and the Toraymyxin therapeutic (PMX). If approved, this will be the first theranostics product, a targeted therapy guided by a specific diagnostic, in the area of sepsis. The company also manufactures and sells certain proprietary reagents.
No comments:
Post a Comment